Rieders Travis Law Firm Logo

ATTORNEYS AT LAW

CALL FOR A FREE CONSULT

(570) 323-8711

    GET HELP NOW - email us


    Diabetes Drug Lawsuit Attorneys

    IF YOU ARE SUFFERING FROM TYPE 2 DIABETES, YOU PROBABLY EXPECT THAT THE MEDICATIONS PRESCRIBED FOR YOU WILL BE BENEFICIAL; UNFORTUNATELY, SOME OF THESE DRUGS HAVE BEEN MAKING PATIENTS SICKER AND HAVE EVEN LED TO DEATH.

    In May 2015, The Institute for Safe Medication Practices (ISMP) warned the Food and Drug Administration (FDA) of adverse reactions linked to Sodium-glucose co-transporter (SGLT2) inhibitor drugs that include Invokana, Invokamet, Jardiance, Xigduo XR, Glyxambi and Farxiga. Damages in patients who took these drugs since March 2013 include kidney failure, heart attacks or ketoacidosis.

    As a result, The FDA has issued a warning about kidney problems and diabetic ketoacidosis, and Invokana lawsuits have been filed against Janssen Pharmaceuticals and Johnson & Johnson for damaging side effects, including an increased risk of kidney problems and cardiovascular problems.

    inner-content-img1If you or a loved one has been injured from side effects of diabetes medications, you may be entitled to compensation for injuries and other losses. Cliff Rieders, seasoned diabetes drug lawsuit attorney at Rieders, Travis, Humphrey, Waters & Dohrmann, is a leader in the field and is known for settling cases efficiently and litigating cases with maximum compensation. Contact Cliff Rieders today to learn what your legal options are — the consultation is free.

    About The Drugs

    Sodium-glucose co-transporter (SGLT2) inhibitors are the newest class of type 2 diabetes medications. Invokana was approved first, despite the drug’s potential link to heart attack. Farxiga, which had its original application denied by the FDA due to concerns of the effect on the liver, was approved in 2014. Jardiance was then approved despite reports it caused test subjects to develop diabetic ketoacidosis. And the latest type 2 diabetes drug, Invokamet XR (canagliflozin and metformin) extended release, was also approved.

    Patients like these drugs because they make it easier to manage the disease, but it has become increasingly obvious that if you suffer the side effects, the risks of taking these medications far outweigh the reward.

    Some of the side effects are mild and include yeast and urinary tract infections, sun intolerance and skin rash.

    More severe side effects that have been reported include:

    • Hypotension (low blood pressure)
    • Changes in blood work
    • Decreases in kidney function
    • Other allergic reactions.

    Makers of SGLT2 inhibitors have been ordered by the FDA to conduct additional testing to determine the safety of their medications, especially the effect on the liver, heart, and bones, and whether there is an increased cancer risk. But one of the most serious and concerning issues to arise from SGLT2 inhibitors is the development of diabetic ketoacidosis.

    Diabetic Ketoacidosis

    Diabetic ketoacidosis (DKA) is caused when the body is unable to use glucose for energy and uses stored fat instead. When this happens, something called ketones build up in the blood stream. Initial symptoms are mild, and patients often don’t realize there is a problem until the condition has become dangerous.

    Early Symptoms include:

    Drug Injury

    • Excessive thirst and hunger
    • Weakness
    • Fatigue
    • Dizziness
    • Excessive urination
    • Gastrointestinal disturbances including nausea and pain
    • Irritability
    • Sweating
    • Rapid heartbeat
    • Shortness of breath.

    As the condition worsens, symptoms include difficulty breathing, nausea, vomiting, abdominal pain, confusion, unusual fatigue or sleepiness, and unconsciousness.

    It is important to immediately contact your doctor and seek medical attention if any of these signs occur.

    If no one recognizes the source of the problem, it can eventually lead to brain swelling and death.

    SGLT2 Inhibitor Lawsuits

    By law, drug manufacturers are strictly liable for injuries if the product they sell is defective, unreasonably dangerous, has design flaws, or if they have not warned consumers of bad effects from the drugs. If you experience any side effects from SGLT2 drugs, you may be entitled to compensation from the manufacturer.

    There are an increasing number of lawsuits being filed against manufacturers of SGLT2 for marketing defective and dangerous drugs, misrepresenting and concealing known drug risks, failing to adequately warn the public of known drug risks, negligence, and illegal marketing of medications. The attorneys for plaintiffs claim that the manufacturers did not properly warn doctors and their patients of the risks involved with the drugs. Had they done so, doctors or patients might have chosen a different diabetes drug, or at least have done testing to monitor if patients were having serious side effects.

    Since there have been so many similar lawsuits brought for these problems, many cases were recently consolidated in a multidistrict legislation case (MDL) in New Jersey federal court in December 2016. So far, litigation against Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, involves 55 lawsuits — and that is only for Invokana and Invokamet.

    Cliff Rieders is a Past President of the Pennsylvania Association for Justice, formerly Pennsylvania Trial Lawyers Association, and is a Board Certified trial lawyer.

    Rieders wrote the book on Medical Malpractice in Pennsylvania, and has been involved in numerous multi-district litigation cases. Many firms that accept these cases are national advertisers and are not in a position to give personal care and attention to each case. Further, you may be much more comfortable with a Pennsylvania attorney than somebody you will never see in another state. Call Cliff Rieders today if you have been harmed by a dangerous diabetes drug — (570) 323-8711.

    If You Have Suffered Serious Side Effects or Injuries From Unsafe Medicines Our Attorneys Are Here to Help

    Dangerous drug cases are very complicated, so it is essential to have experienced attorneys and legal staff on your side. Whether in settlement negotiations or pursuing a favorable trial verdict, Pennsylvania personal injury attorney Cliff Rieders of Rieders, Travis, Humphrey, Waters & Dohrmann is familiar with the law regarding dangerous drugs and is thoroughly prepared and committed to achieving a just outcome. With the firm’s sizeable staff, we offer strength in numbers to do research and to pursue your interests in court, while providing top-notch personal service.

    If you or your loved one has suffered injury from pharmaceuticals or any other type of medical malpractice, time is of the essence, so don’t delay. Contact Cliff Rieders, Pennsylania medical malpractice lawyer with the firm of Rieders, Travis, Humphrey, Waters & Dohrmann, by calling (570) 323-8711 or by using our online contact form. Based in Williamsport, we serve clients throughout the state of Pennsylvania, offering a free consultation on all medical malpractice matters. We are dedicated to providing the legal support you need to have a successful case, and we offer you experience, knowledge, compassion, and a long history of results.

    Attorney Cliff Rieders

    Attorney Cliff RiedersCliff Rieders is a Nationally Board Certified Trial Lawyer practicing personal injury law. A large part of his practice involves multi-district litigation, including cases related to pharmaceuticals, vitamin supplements and medical devices. He is admitted in several state and federal courts, as well as the Supreme Court of the United States. Rieders is the past regional president of the Federal Bar Association and is a life member of the distinguished American Law Institute, which promulgates proposed rules adopted by many state courts. He is a past president of the Pennsylvania Association for Justice, formerly Pennsylvania Trial Lawyers Association. As a founder of the Pennsylvania Patient Safety Authority, he served on the Board for 15 years.

    Not only has Rieders held many highly esteemed, leadership positions, he authored legislation related to the Patient Safety Authority and the Mcare Act, which governs medical and hospital liability actions in Pennsylvania. He authored texts upon which both practitioners and judges rely, including Pennsylvania Malpractice Laws and Forms, and Financial Responsibility Law Issues in Pennsylvania, the latter governing auto and truck collisions in Pennsylvania. In addition, he wrote several books on the practice of law in Pennsylvania regarding wrongful death and survivor actions, insurance bad faith, legal malpractice claims and worker rights, among others. Rieders also serves as a resource to practitioners as a regular speaker for Celesq, an arm of the world’s largest legal publisher, Thomson Reuters West Publishing.

    As recognition of his wide range of contribution to his profession and of his dedication to protecting the rights of his clients, he received numerous awards, among them the George F. Douglas Amicus Curiae Award, the Milton D. Rosenberg Award, the B’nai B’rith Justice Award, and awards of recognition from the Pennsylvania Trial Lawyers. [ Attorney Bio ]

    Table of Contents

    Our Legal Team

    AttorneyClifford A. Rieders
    Partner
    Jeffrey C. Dohrmann
    AttorneyJeffrey C. Dohrmann
    Partner
    Corey J. Mowrey
    AttorneyCorey J. Mowrey
    Associate
    Attorney John Humphrey
    AttorneyJohn M. Humphrey
    Partner
    Attorney Walter
    AttorneyC. Scott Waters
    Partner
    Pamela L. Shipman
    AttorneyPamela L. Shipman
    Associate

    RECENT ARTICLES

    • COVID-19-DEATH CASE

      PA Drug Injury AttorneyTesta v. Broomall, Pa. Civil No. 21-5148-KSM (E.D. Pa. August 18, 2022) (Marston, J.)  COVID-19 death case in a nursing home.  Motion to dismiss denied.  The claim was based upon the fact that although decedent tested positive for COVID-19, she was permitted to travel out of her room to interact with other residents and to get her nails done while she was placed in isolation.  She had a “win...

    • MEDICAL MALPRACTICE-PRIVILEGE
    • MEDICAL MALPRACTICE-COVID-19-NURSING HOME

    SIGN UP FOR OUR NEWSLETTER